2022
DOI: 10.1016/j.biopha.2022.113797
|View full text |Cite
|
Sign up to set email alerts
|

Natural products targeting the ATR-CHK1 signaling pathway in cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 106 publications
0
7
0
Order By: Relevance
“…The major substrates of Chk1 are Wee1, CDC25A, and CDC25C. Phosphorylation of these proteins leads to functional inhibition of CDK1 and CDK2, which in turn results in temporary suppression of the cell cycle to prevent abnormal cell division and permanent loss of genetic material 29 . Because of the observed involvement of claspin in SFB‐mediated cancer cell apoptosis, we next investigated the expressions of proteins involved in the ATR‐Chk1 signaling pathway.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The major substrates of Chk1 are Wee1, CDC25A, and CDC25C. Phosphorylation of these proteins leads to functional inhibition of CDK1 and CDK2, which in turn results in temporary suppression of the cell cycle to prevent abnormal cell division and permanent loss of genetic material 29 . Because of the observed involvement of claspin in SFB‐mediated cancer cell apoptosis, we next investigated the expressions of proteins involved in the ATR‐Chk1 signaling pathway.…”
Section: Resultsmentioning
confidence: 99%
“…30 In accordance to our findings, previous studies have shown that natural bioactive compounds can exert anticancer effects by targeting the ATR-Chk1 signaling pathway. 29 A study analyzing bioactive compounds of Curcuma longa has found that curcumin suppresses three major DNA damage response pathways by inhibiting ATR and histone acetyltransferases, which in turn induce mitotic catastrophe and cancer cell death. These events are collectively responsible for curcuminmediated sensitization of cancer cells to PARP inhibitors.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Chemotherapeutic drugs that target replicating DNA cells activate the ATR-CHK1 pathway ( da Costa et al, 2023 ). Additionally, inhibitors of ATR-CHK1 have been reported to decrease the levels of P-gp ( Ahmed et al, 2022 ).…”
Section: The Mechanism Of Mdrmentioning
confidence: 99%
“…Natural products, including curcumin, mangostin, resveratrol, and carnosine, block the G1-S phase but not affect the cell division cycle of proliferating healthy cells. Studies have shown that resveratrol, mangostin, and carnosine are agonists of ATR-CHK1, and kaempferol, curcumin, raffinose, and caffeine are inhibitors of ATR-CHK1, and these phytochemicals may help overcome tumor resistance ( Ahmed et al, 2022 ). PU-1 is a sesquiterpenoid derived from Asteraceae that inhibits the growth of drug-resistant tumor cells through DNA damage, G2/M cell cycle blockade and apoptosis ( Hegazy et al, 2021 ) ( Figure 1 ).…”
Section: The Mechanism Of Mdrmentioning
confidence: 99%